Contributors |
|
xiii | |
Woodhead Publishing Series in Biomaterials |
|
xvii | |
|
1 Advanced cardiac imaging |
|
|
1 | (12) |
|
|
|
|
|
|
1 | (1) |
|
|
1 | (2) |
|
|
3 | (5) |
|
1.4 Shared themes and challenges |
|
|
8 | (3) |
|
|
11 | (2) |
|
Part One Technological Developments in Cardiac Imaging |
|
|
13 | (158) |
|
2 Ultrasound/echocardiography |
|
|
15 | (32) |
|
|
|
|
15 | (1) |
|
2.2 Three-dimensional echocardiography |
|
|
16 | (7) |
|
2.3 Contrast echocardiography |
|
|
23 | (9) |
|
|
32 | (7) |
|
|
39 | (6) |
|
|
45 | (2) |
|
|
45 | (2) |
|
3 Single-photon emission computed tomography |
|
|
47 | (24) |
|
|
P.A. Kaufmann O. Gaemperli |
|
|
|
47 | (1) |
|
3.2 Physical principles of SPECT |
|
|
47 | (3) |
|
|
50 | (4) |
|
|
54 | (2) |
|
3.5 Image processing and reconstruction |
|
|
56 | (6) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
64 | (7) |
|
|
67 | (4) |
|
4 Positron emission tomography |
|
|
71 | (26) |
|
|
|
|
71 | (1) |
|
|
71 | (7) |
|
4.3 Clinical applications |
|
|
78 | (12) |
|
|
90 | (7) |
|
|
91 | (6) |
|
|
97 | (30) |
|
|
|
|
5.1 Development of cardiac CT |
|
|
97 | (1) |
|
5.2 Technical principles and contemporary technology |
|
|
97 | (9) |
|
5.3 CT performance, image quality parameters, and artifacts |
|
|
106 | (5) |
|
5.4 Cardiac CT applications |
|
|
111 | (5) |
|
5.5 Postprocessing, secondary reconstruction, and assisted interpretation |
|
|
116 | (1) |
|
5.6 Radiation and dose reduction |
|
|
117 | (3) |
|
5.7 Estimating the hemodynamic significance of CAD |
|
|
120 | (3) |
|
|
123 | (4) |
|
|
123 | (4) |
|
6 Magnetic resonance imaging |
|
|
127 | (44) |
|
|
|
|
|
|
|
|
127 | (1) |
|
6.2 Basic principles of NMR |
|
|
127 | (8) |
|
|
135 | (3) |
|
6.4 Perfusion, blood-oxygen-level-dependent, and late gadolinium enhancement imaging |
|
|
138 | (3) |
|
6.5 Quantitative mapping techniques |
|
|
141 | (5) |
|
6.6 Three-dimensional time-resolved (4D) flow |
|
|
146 | (2) |
|
6.7 Magnetic resonance spectroscopy |
|
|
148 | (3) |
|
|
151 | (4) |
|
6.9 Latest technical developments and future trends |
|
|
155 | (1) |
|
6.10 Sources of further information |
|
|
156 | (15) |
|
|
157 | (1) |
|
|
158 | (13) |
|
Part Two Clinical Applications of Cardiac Imaging |
|
|
171 | (594) |
|
7 Noninvasive coronary angiography |
|
|
173 | (30) |
|
|
|
|
173 | (1) |
|
7.2 Coronary artery calcium |
|
|
173 | (3) |
|
7.3 CT coronary angiography |
|
|
176 | (13) |
|
|
189 | (1) |
|
|
190 | (1) |
|
7.6 Coronary magnetic resonance imaging |
|
|
190 | (13) |
|
|
193 | (10) |
|
|
203 | (24) |
|
|
|
|
203 | (1) |
|
8.2 Non-invasive imaging of atherosclerosis |
|
|
204 | (2) |
|
|
206 | (11) |
|
|
217 | (10) |
|
|
217 | (10) |
|
|
227 | (44) |
|
|
|
|
227 | (1) |
|
9.1 Pathophysiology of ischemia |
|
|
227 | (7) |
|
9.2 Invasive diagnosis of ischemia |
|
|
234 | (5) |
|
9.3 Noninvasive detection and quantification of ischemia |
|
|
239 | (22) |
|
|
261 | (1) |
|
9.5 Risk stratification and prognosis |
|
|
261 | (3) |
|
9.6 Noninvasive follow-up of the patient with known coronary artery disease |
|
|
264 | (7) |
|
|
264 | (7) |
|
|
271 | (56) |
|
|
|
|
|
|
|
|
|
271 | (9) |
|
|
280 | (8) |
|
|
288 | (9) |
|
|
297 | (6) |
|
|
303 | (9) |
|
10.6 Guidelines for use of imaging in AMI |
|
|
312 | (1) |
|
|
313 | (14) |
|
|
313 | (14) |
|
|
327 | (40) |
|
|
|
|
|
|
11.1 Background, terms, and definitions |
|
|
327 | (5) |
|
11.2 Multimodality imaging for myocardial viability assessment |
|
|
332 | (15) |
|
11.3 The role of myocardial viability assessment in clinical decision-making |
|
|
347 | (6) |
|
11.4 Current research, emerging techniques, and hybrid imaging |
|
|
353 | (2) |
|
|
355 | (12) |
|
|
355 | (1) |
|
|
355 | (12) |
|
12 Contractile function and heart failure |
|
|
367 | (32) |
|
|
|
|
|
|
367 | (2) |
|
12.2 Echocardiography approach to the LV contractility |
|
|
369 | (5) |
|
12.3 Assessment of RV function |
|
|
374 | (9) |
|
12.4 Assessment of contractile function by CMR |
|
|
383 | (4) |
|
12.5 Assessment of ventricular function using radionuclide techniques |
|
|
387 | (12) |
|
|
392 | (7) |
|
|
399 | (40) |
|
|
|
|
399 | (7) |
|
13.2 Dilated cardiomyopathy |
|
|
406 | (5) |
|
13.3 Non-compaction cardiomyopathy |
|
|
411 | (2) |
|
13.4 Stress (Takotsubo) cardiomyopathy |
|
|
413 | (1) |
|
13.5 Arrhythmogenic (right) ventricular cardiomyopathy |
|
|
414 | (2) |
|
13.6 Hypertrophic cardiomyopathy |
|
|
416 | (5) |
|
13.7 Hypertrophic phenocopies |
|
|
421 | (1) |
|
13.8 Infiltrative disease/restrictive cardiomyopathy |
|
|
422 | (5) |
|
13.9 Cardiac iron overload |
|
|
427 | (1) |
|
13.10 Pericardial constriction |
|
|
428 | (1) |
|
13.11 Limitations of imaging |
|
|
428 | (1) |
|
13.12 Likely future trends |
|
|
428 | (1) |
|
13.13 Conclusions and reflection |
|
|
429 | (10) |
|
|
430 | (1) |
|
|
431 | (8) |
|
|
439 | (20) |
|
|
|
|
439 | (2) |
|
14.2 Biopsy as "the invasive standard" |
|
|
441 | (2) |
|
|
443 | (1) |
|
|
443 | (11) |
|
|
454 | (5) |
|
|
454 | (5) |
|
|
459 | (30) |
|
|
|
|
15.1 Arterial systemic hypertension |
|
|
459 | (6) |
|
15.2 Diabetic cardiomyopathy |
|
|
465 | (2) |
|
15.3 Inotropic reserve in diabetic patients |
|
|
467 | (2) |
|
|
469 | (3) |
|
15.5 Autoimmune connective tissue disorders |
|
|
472 | (2) |
|
|
474 | (1) |
|
|
475 | (14) |
|
|
478 | (11) |
|
16 Acquired valvular heart disease |
|
|
489 | (96) |
|
|
489 | (1) |
|
|
|
|
16.1 Annulus size and calcification |
|
|
489 | (2) |
|
16.2 Aortic valve leaflets |
|
|
491 | (2) |
|
16.3 Sinus of Valsalva and sinotubular junction |
|
|
493 | (3) |
|
|
494 | (2) |
|
|
496 | (1) |
|
|
|
|
16.4 Aortic valve/root morphology |
|
|
496 | (1) |
|
16.5 Severity of aortic stenosis |
|
|
496 | (4) |
|
|
500 | (3) |
|
|
500 | (3) |
|
|
503 | (1) |
|
|
|
|
16.7 Aortic valve/root morphology |
|
|
503 | (1) |
|
16.8 Severity of aortic regurgitation |
|
|
503 | (7) |
|
|
508 | (2) |
|
|
510 | (1) |
|
|
|
510 | (1) |
|
16.10 Aetiology and mechanisms |
|
|
510 | (1) |
|
16.11 2D/3D echocardiographic evaluation |
|
|
511 | (7) |
|
16.12 Cardiac magnetic resonance |
|
|
518 | (3) |
|
16.13 Multislice cardiac computed tomography |
|
|
521 | (1) |
|
|
522 | (4) |
|
|
523 | (3) |
|
Tricuspid and pulmonary valves |
|
|
526 | (1) |
|
|
|
|
|
526 | (7) |
|
|
533 | (8) |
|
|
540 | (1) |
|
|
541 | (1) |
|
|
|
|
541 | (1) |
|
|
541 | (1) |
|
|
542 | (15) |
|
|
557 | (2) |
|
16.20 Computed tomography |
|
|
559 | (3) |
|
|
562 | (1) |
|
16.22 Magnetic resonance imaging |
|
|
562 | (1) |
|
|
563 | (4) |
|
|
563 | (4) |
|
Interventional imaging for transcatheter valve procedures |
|
|
567 | (1) |
|
|
|
16.24 Transcatheter aortic valve implantation |
|
|
567 | (1) |
|
16.25 Transoesophageal echocardiography approach before TAVI |
|
|
567 | (1) |
|
16.26 Transoesophageal echocardiography during prosthesis implantation |
|
|
568 | (1) |
|
16.27 Percutaneous transcatheter repair of paravalvular regurgitation |
|
|
569 | (1) |
|
16.28 TEE before transcatheter repair of paravalvular regurgitation |
|
|
569 | (1) |
|
16.29 TEE during percutaneous transcatheter repair of paravalvular regurgitation |
|
|
570 | (1) |
|
16.30 Percutaneous mitral valve intervention by edge-to-edge repair |
|
|
571 | (1) |
|
16.31 TEE for patients selection for edge-to-edge repair |
|
|
571 | (1) |
|
16.32 TEE during edge-to-edge repair |
|
|
571 | (1) |
|
|
572 | (2) |
|
|
573 | (1) |
|
|
574 | (1) |
|
|
|
|
|
574 | (1) |
|
|
574 | (3) |
|
|
577 | (3) |
|
16.37 Multislice computed tomography |
|
|
580 | (1) |
|
16.38 Magnetic resonance imaging |
|
|
581 | (1) |
|
|
581 | (4) |
|
|
581 | (4) |
|
|
585 | (32) |
|
|
|
|
|
585 | (1) |
|
|
585 | (3) |
|
17.3 Cardiovascular magnetic resonance |
|
|
588 | (3) |
|
17.4 Cardiac computed tomography |
|
|
591 | (1) |
|
17.5 Nuclear imaging techniques |
|
|
591 | (2) |
|
|
593 | (17) |
|
|
610 | (7) |
|
|
612 | (5) |
|
|
617 | (18) |
|
|
|
|
|
617 | (1) |
|
|
617 | (3) |
|
18.3 The pericardium: normal findings |
|
|
620 | (1) |
|
|
621 | (8) |
|
18.5 Cardiac masses (cysts, diverticula, hematoma, tumors) |
|
|
629 | (3) |
|
18.6 Congenital absence of pericardium |
|
|
632 | (3) |
|
|
633 | (2) |
|
19 Congenital heart disease |
|
|
635 | (26) |
|
|
|
Abbreviations and acronyms |
|
|
635 | (1) |
|
|
635 | (1) |
|
|
636 | (5) |
|
|
641 | (14) |
|
|
655 | (6) |
|
|
655 | (6) |
|
20 Diseases of the thoracic aorta and pulmonary arteries |
|
|
661 | (46) |
|
|
|
|
|
|
661 | (1) |
|
20.2 Acute aortic syndrome |
|
|
661 | (14) |
|
|
675 | (6) |
|
20.4 Imaging of the postoperative aorta |
|
|
681 | (5) |
|
20.5 Pulmonary circulation |
|
|
686 | (8) |
|
20.6 Aneurysmatic disease |
|
|
694 | (13) |
|
|
702 | (5) |
|
|
707 | (28) |
|
|
|
|
|
707 | (1) |
|
|
707 | (4) |
|
|
711 | (6) |
|
|
717 | (3) |
|
21.5 Cardiac magnetic resonance imaging |
|
|
720 | (4) |
|
21.6 Electroanatomic mapping |
|
|
724 | (2) |
|
21.7 Radionuclide imaging |
|
|
726 | (1) |
|
|
727 | (8) |
|
|
729 | (6) |
|
22 Imaging guided interventions |
|
|
735 | (30) |
|
|
|
|
|
735 | (1) |
|
22.2 Transcatheter aortic valve implantation |
|
|
735 | (9) |
|
22.3 Percutaneous edge-to-edge repair of the mitral valve |
|
|
744 | (7) |
|
22.4 Occlusion of left atrial appendage |
|
|
751 | (7) |
|
22.5 Interventional closure of ASD and PFO |
|
|
758 | (1) |
|
22.6 Interventional closure of paravalvular leaks |
|
|
759 | (2) |
|
22.7 Pre-interventional imaging in coronary CTO |
|
|
761 | (4) |
|
|
762 | (3) |
Index |
|
765 | |